Drug majors Dr Reddy’s Lab and Lupin are recalling over 1.7 lakh bottles of two different tablets, used in the treatment of blood pressure and acidity, in the US due to deviations from manufacturing norms.

Dr Reddy’s Laboratories, its US arm Dr Reddy’s Laboratories Inc, is recalling 84,240 bottles of Famotidine 10 mg tablets, according to the latest Enforcement Report of United States Food and Drug Administration (USFDA).

Lupin’s US subsidiary, Lupin Pharmaceuticals Inc, is recalling 59,520 bottles of Lisinopril & Hydrochlorothiazid tablets USP 20mg/12.5mg, 5,880 bottles of Lisinopril tablets, USP 40 mg and 20,587 bottles of Lisinopril tablets, USP 30mg due to deviation from current good manufacturing practice (CGMP).

Dr Reddys Laboratories Ltd is currently trading at Rs. 3499.4, up by Rs. 51.7 or 1.5% from its previous closing of Rs. 3447.7 on the BSE. The scrip opened at Rs. 3480 and has touched a high and low of Rs. 3511.05 and Rs. 3475.4 respectively. So far 237776(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 58820.4 crore.

Lupin Ltd is currently trading at Rs. 1556.65, down by Rs. 3.2 or 0.21% from its previous closing of Rs. 1559.85 on the BSE. The scrip opened at Rs. 1563 and has touched a high and low of Rs. 1569.1 and Rs. 1554.05 respectively. So far 178963(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 70331.04 crore.